The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria
Open accessAbstract
Objective: The American College of Rheumatology (ACR) 1990 fibromyalgia classification criteria are based on the presence of widespread pain and tenderness. In 2010, new criteria were proposed that focused more on multiple symptoms, and these criteria were later modified to require only self report of symptoms. The current study aimed to determine the population prevalence of fibromyalgia and to compare differences in prevalence using the alternative criteria. Methods: A cross‐sectional survey was conducted. Questionnaires, including items on pain, symptoms, and rheumatologic diagnoses, were mailed to 4,600 adults in northeast Scotland. Participants who had chronic widespread pain or those who met the modified 2010 criteria, plus a subsample of other participants, were invited to attend a research clinic. Attendees completed an additional questionnaire and underwent a rheumatologic examination, and their signs and symptoms were classified according to the ACR 1990, 2010, and modified 2010 criteria. The prevalence of fibromyalgia according to each set of criteria was calculated, weighting back to the target population by age, sex, and area of residence. Results: Of 1,604 questionnaire participants, 269 were invited to attend the research clinic, and 104 (39%) attended; 32 of these subjects (31%) met ≥1 set of fibromyalgia criteria. The prevalence of fibromyalgia according to the 1990, 2010, and modified 2010 criteria was 1.7% (95% confidence interval [95% CI] 0.7–2.8), 1.2% (95% CI 0.3–2.1), and 5.4% (95% CI 4.7–6.1), respectively. The ratio of females to males was 13.7:1, 4.8:1, and 2.3:1 of those meeting the respective criteria sets. Conclusion: Fibromyalgia prevalence varies with the different sets of classification criteria applied. In particular, prevalence is higher and a greater proportion of men are identified with the modified 2010 criteria as compared to the criteria sets requiring clinician input. This has important implications for the use of the new criteria, both in research and in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 1×
“These criteria have not been formally adopted and are only “approved by the ACR Board of Directors as provisional” (7).”
BackgroundWolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
WOLFE, F., CLAUW, D. J., FITZCHARLES, M.-A., GOLDENBERG, D. L., HÄUSER, W., KATZ, R. S., MEASE, P., RUSSELL, A. S., RUSSELL, I. J., & WINFIELD, J. B. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100594 · Cited by 1,499
Carmona, L., Ballina, J., Gabriel, R., & Laffon, A. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.11.1040 · Cited by 636
Reporting Participation in Epidemiologic Studies: A Survey of Practice
Morton, L. M., Cahill, J., & Hartge, P. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj036 · Cited by 461
Wolfe, F., Brähler, E., Hinz, A., & Häuser, W. (2013) · Arthritis Care & Research · doi:10.1002/acr.21931 · Cited by 443
White, K. P., Speechley, M. R., Harth, M., & Østbye, T. (1999) · PubMed · Cited by 410
Bennett, R. M., Friend, R. M., Marcus, D. A., Bernstein, C., Han, B. K., Yachoui, R., Deodhar, A. A., Kaell, A. T., Bonafede, P., Chino, A. F., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22301 · Cited by 171
Validation of the Fibromyalgia Survey Questionnaire within a Cross-Sectional Survey
Häuser, W., Jung, E., Erbslöh-Möller, B., Gesmann, M., Kühn-Becker, H., Petermann, F., Langhorst, J., Weiss, T., Winkelmann, A., & Wolfe, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037504 · Cited by 153
Cited by
2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Häuser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.08.012 · Cited by 2,232
Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies
Fayaz, A., Croft, P., Langford, R. M., Donaldson, L. J., & Jones, G. T. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010364 · Cited by 1,355
Self-citationFibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 793
Self-citationFibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update
Siracusa, R., Paola, R. D., Cuzzocrea, S., & Impellizzeri, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083891 · Cited by 659
Häuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.22 · Cited by 505
AAPT Diagnostic Criteria for Fibromyalgia
Arnold, L. M., Bennett, R. M., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., Fitzcharles, M.-A., Paiva, E. S., Staud, R., Sarzi-Puttini, P., et al. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.10.008 · Cited by 420
Self-citationPrevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis
Heidari, F., Afshari, M., & Moosazadeh, M. (2017) · Rheumatology International · doi:10.1007/s00296-017-3725-2 · Cited by 432
Bair, M. J., & Krebs, E. E. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202003030 · Cited by 298
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 275
Fibromyalgia and related conditions
Clauw, D. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.014 · Cited by 259
Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
Galvez-Sánchez, C. M., & Reyes del Paso, G. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041219 · Cited by 241
Haroutounian, S., Ratz, Y., Ginosar, Y., Furmanov, K., Saifi, F., Meidan, R., & Davidson, E. (2016) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000364 · Cited by 234
Grayston, R., Czanner, G., Elhadd, K., Goebel, A., Frank, B., Üçeyler, N., Malik, R. A., & Alam, U. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.08.003 · Cited by 213
Creed, F. (2020) · Pain · doi:10.1097/j.pain.0000000000001819 · Cited by 135
Current and Emerging Pharmacotherapy for Fibromyalgia
Tzadok, R., & Ablin, J. N. (2020) · Pain Research and Management · doi:10.1155/2020/6541798 · Cited by 122
“Fibromyalgia syndrome (FMS) is a common pain disorder, characterized by chronic generalized pain, with a population-estimated prevalence of 1–5% [1].”
BackgroundNutritional Interventions in the Management of Fibromyalgia Syndrome
Pagliai, G., Giangrandi, I., Dinu, M., Sofi, F., & Colombini, B. (2020) · Nutrients · doi:10.3390/nu12092525 · Cited by 113
Ting, T. V., Barnett, K., Lynch-Jordan, A., Whitacre, C., Henrickson, M., & Kashikar-Zuck, S. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.011 · Cited by 88
Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients
Costantini, R., Affaitati, G., Wesselmann, U., Czakanski, P., & Giamberardino, M. A. (2017) · Pain · doi:10.1097/j.pain.0000000000000992 · Cited by 76
Martin, L., Porreca, F., Mata, E. I., Salloum, M., Goel, V., Gunnala, P., Killgore, W. D. S., Jain, S., Jones-MacFarland, F. N., Khanna, R., et al. (2021) · Pain Medicine · doi:10.1093/pm/pnaa329 · Cited by 62
Eccles, J. A., Thompson, B., Themelis, K., Amato, M. L., Stocks, R., Pound, A., Jones, A.-M., Cipinova, Z., Shah-Goodwin, L., Timeyin, J., et al. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-0743 · Cited by 55
Singh, L., Kaur, A., Bhatti, M. S., & Bhatti, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02805-5 · Cited by 55
Challenges in Fibromyalgia Diagnosis: From Meaning of Symptoms to Fibromyalgia Labeling
Bidari, A., Parsa, B. G., & Ghalehbaghi, B. (2018) · The Korean Journal of Pain · doi:10.3344/kjp.2018.31.3.147 · Cited by 49
Galvez-Sánchez, C. M., Montoro, C. I., Moreno-Padilla, M., Reyes del Paso, G. A., & de la Coba, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122706 · Cited by 45
“Although the prevalence rates of FMS are similar using both sets of diagnostic criteria (slightly higher than 2% of the general population) [17,18], use of the updated ACR diagnostic criteria may increase the prevalence rates [19,20].”
MethodT. Jones, G. (2016) · Current Rheumatology Reviews · doi:10.2174/1573397112666151231113438 · Cited by 43
Mast cell activation disease and the modern epidemic of chronic inflammatory disease
Afrin, L. B. (2016) · Translational Research · doi:10.1016/j.trsl.2016.01.003 · Cited by 39
Gardoki-Souto, I., Redolar-Ripoll, D., Fontana, M., Hogg, B., Castro, M. J., Blanch, J. M., Ojeda, F., Solanes, A., Radua, J., Valiente-Gómez, A., et al. (2022) · Pain Research and Management · doi:10.1155/2022/2114451 · Cited by 36
Poole, J. L., & Siegel, P. (2017) · American Journal of Occupational Therapy · doi:10.5014/ajot.2017.023192 · Cited by 41
Pedersen, H. F., Agger, J. L., Frostholm, L., Jensen, J. S., Ørnbøl, E., Fink, P., & Schröder, A. (2019) · Psychological Medicine · doi:10.1017/s0033291718001666 · Cited by 24
Cojocaru, C. M., Popa, C. O., Schenk, A., Suciu, B. A., & Szasz, S. (2023) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2661 · Cited by 21
“The prevalence of this medical condition in the general population was estimated between 1.7% and 5.4%, presenting an increased frequency among women [3].”
BackgroundInfluentialAlciati, A., Cirillo, M., Masala, I. F., Sarzi‐Puttini, P., & Atzeni, F. (2021) · Stress and Health · doi:10.1002/smi.2992 · Cited by 20
Self-citationFibromyalgia pathogenesis explained by a neuroendocrine multistable model
Demori, I., Losacco, S., Giordano, G., Mucci, V., Blanchini, F., & Burlando, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0303573 · Cited by 14
Jakobsson, J. E., Menezes, J., Krock, E., Hunt, M. A., Carlsson, H., Vaivade, A., Emami Khoonsari, P., Agalave, N. M., Sandström, A., Kadetoff, D., et al. (2025) · The Journal of Pain · doi:10.1016/j.jpain.2025.105331 · Cited by 9
Lahat-Birka, N., Boussi-Gross, R., Ben Ari, A., Efrati, S., & Ben-David, S. (2024) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000001236 · Cited by 5
Metadata
- Authors
- Jones, G. T., Atzeni, F., Beasley, M., Flüß, E., Sarzi‐Puttini, P., & Macfarlane, G. J.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2015-01-28
- Volume
- 67
- Issue
- 2
- Pages
- 568-575
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W1950256523
- Cited by
- 460
- References
- 18
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.